"Cancer cells also need to 'eat' things to survive, depriving it of food, cancer cells will die." Zhejiang University Cancer Institute Professor Hu said, is following this seemingly simple principle, he and the research team found together The "starved to death" cancer cells of the new therapy, and published in the international biological and medical field authoritative magazine elife, has been recognized by the world famous tumor scholars.

After years of basic research, Hu flood found that glucose is cancer cells must "eat" things, according to care to see deprivation of glucose cancer cells will die. But in fact the lack of glucose supply, the tumor is not starved to death is also growing.

Professor Hu flooding out of which the mystery: a large number of lactic acid in the tumor, lactic acid dissociation into lactate anion and hydrogen ions, as cancer cells of the two "helper", so that its own according to the "food" the number of decisions "consumption" How many.

Two "helper" synergies, making the cancer cells in the glucose content is very small, very economical use of glucose; in the absence of glucose into the "dormant" state; when there is glucose supply immediately resume the growth state.

Therefore, if you want to effectively "starve" cancer cells, not only to deprive glucose, need to destroy the lactate anion and hydrogen ions synergies. In the glucose hunger or lack of the premise, as long as the removal of any of these two factors, cancer cells will die quickly.

Researchers with alkali, such as sodium bicarbonate (baking soda) to remove the hydrogen ions within the tumor, can destroy the synergistic effect of lactate and hydrogen ions, so quickly and effectively kill the glucose starvation or lack of tumor cells.

Will be the basic scientific research results into cancer clinical treatment, so that more patients benefit is the key.

Since 2012, with 30 years of clinical experience of the Zhejiang University Medical College Affiliated Hospital of the second interventional surgeon Chao Ming and Hu flood team hit it off, into the primary hepatocellular carcinoma of the new study of liver cancer, and this method named "Intra-tumor anionic and hydrogen-induced arterial chemoembolization", referred to as "TILA-TACE".

Clinically, Chao Ming explained: "conventional arterial chemoembolization (cTACE) cut off the tumor 'food channel', and then we use sodium bicarbonate to remove the hydrogen ions within the tumor, the equivalent of not only not to the tumor ' Eat ', but also let it go to the gym quickly consumed, quickly' starved to death '.

Surprisingly, the results of their clinical studies showed that 37 patients were treated with cTACE and 18 were effective; 40 patients were treated with TILA-TACE and 40 were effective.

And in this clinical study with TILA-TACE treatment of liver cancer are refractory liver cancer.

The international comprehensive report, cTACE treatment of the average objective and effective rate of 35%. 35% to 100%, such a huge contrast, not only to international colleagues in the acceptance of this article, very cautious, even the two professors have been with the suspicion of the study.

"At present, preliminary statistics, the median survival of patients, has more than three and a half years; follow-up also need a large sample of randomized controlled study, if confirmed effective, for liver cancer treatment, is indeed a leap." Two experts said.